Marshall Wace’s Bruker BRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.96M | Buy |
99,032
+13,592
| +16% | +$634K | ﹤0.01% | 1282 |
|
|
2026
Q1 | $3.09M | Sell |
85,440
-1,008,376
| -92% | -$42.2M | ﹤0.01% | 1553 |
|
|
2025
Q4 | $51.5M | Buy |
+1,093,816
| New | +$46.2M | 0.05% | 338 |
|
|
2025
Q3 | – | Sell |
-6,112
| Closed | -$252K | – | 2915 |
|
|
2025
Q2 | $252K | Buy |
+6,112
| New | +$236K | ﹤0.01% | 2379 |
|
|
2025
Q1 | – | Sell |
-783,988
| Closed | -$46M | – | 2640 |
|
|
2024
Q4 | $46M | Buy |
783,988
+766,983
| +4,510% | +$45.3M | 0.06% | 305 |
|
|
2024
Q3 | $1.17M | Sell |
17,005
-1,372,532
| -99% | -$88.7M | ﹤0.01% | 1587 |
|
|
2024
Q2 | $88.7M | Buy |
1,389,537
+779,549
| +128% | +$58.7M | 0.12% | 161 |
|
|
2024
Q1 | $57.3M | Buy |
+609,988
| New | +$49.1M | 0.09% | 224 |
|
|
2023
Q3 | – | Sell |
-67,846
| Closed | -$5.02M | – | 2217 |
|
|
2023
Q2 | $5.02M | Buy |
+67,846
| New | +$5.17M | 0.01% | 1023 |
|
|
2022
Q3 | – | Sell |
-59,318
| Closed | -$3.72M | – | 3360 |
|
|
2022
Q2 | $3.72M | Sell |
59,318
-110,535
| -65% | -$6.78M | 0.01% | 1565 |
|
|
2022
Q1 | $10.9M | Sell |
169,853
-284,523
| -63% | -$19.5M | 0.02% | 817 |
|
|
2021
Q4 | $38.1M | Sell |
454,376
-276,682
| -38% | -$22.2M | 0.07% | 284 |
|
|
2021
Q3 | $57.1M | Buy |
731,058
+152,571
| +26% | +$12.7M | 0.24% | 68 |
|
|
2021
Q2 | $44M | Buy |
578,487
+424,780
| +276% | +$29.7M | 0.2% | 86 |
|
|
2021
Q1 | $9.88M | Sell |
153,707
-190,263
| -55% | -$11.4M | 0.05% | 456 |
|
|
2020
Q4 | $18.6M | Buy |
343,970
+117,473
| +52% | +$5.63M | 0.1% | 206 |
|
|
2020
Q3 | $9M | Buy |
226,497
+210,483
| +1,314% | +$8.78M | 0.06% | 331 |
|
|
2020
Q2 | $651K | Buy |
+16,014
| New | +$630K | ﹤0.01% | 1121 |
|
|
2020
Q1 | – | Sell |
-112,678
| Closed | -$5.74M | – | 1644 |
|
|
2019
Q4 | $5.74M | Sell |
112,678
-145,581
| -56% | -$6.93M | 0.04% | 484 |
|
|
2019
Q3 | $11.3M | Sell |
258,259
-245,521
| -49% | -$11M | 0.09% | 264 |
|
|
2019
Q2 | $25.2M | Sell |
503,780
-638,946
| -56% | -$26.9M | 0.21% | 100 |
|
|
2019
Q1 | $43.9M | Sell |
1,142,726
-474,391
| -29% | -$17.1M | 0.41% | 40 |
|
|
2018
Q4 | $48.1M | Buy |
1,617,117
+573,547
| +55% | +$18.1M | 0.49% | 31 |
|
|
2018
Q3 | $34.9M | Buy |
1,043,570
+895,860
| +606% | +$29.5M | 0.3% | 84 |
|
|
2018
Q2 | $4.29M | Sell |
147,710
-12,870
| -8% | -$391K | 0.06% | 324 |
|
|
2018
Q1 | $4.8M | Sell |
160,580
-7,835
| -5% | -$254K | 0.2% | 111 |
|
|
2017
Q4 | $5.78M | Buy |
168,415
+7,835
| +5% | +$257K | 0.24% | 97 |
|
|
2017
Q3 | $4.82M | Hold |
160,580
| – | – | 0.22% | 99 |
|
|
2017
Q2 | $4.66M | Buy |
160,580
+9,065
| +6% | +$233K | 0.21% | 98 |
|
|
2017
Q1 | $3.48M | Sell |
151,515
-1,186,325
| -89% | -$27.9M | 0.17% | 105 |
|
|
2016
Q4 | $28.3M | Buy |
1,337,840
+273,465
| +26% | +$5.98M | 0.19% | 150 |
|
|
2016
Q3 | $24.1M | Buy |
1,064,375
+31,034
| +3% | +$711K | 0.17% | 143 |
|
|
2016
Q2 | $23.5M | Buy |
+1,033,341
| New | +$27.6M | 0.2% | 131 |
|
|
2015
Q3 | – | Sell |
-178,476
| Closed | -$3.64M | – | 918 |
|
|
2015
Q2 | $3.64M | Buy |
+178,476
| New | +$3.61M | 0.05% | 353 |
|
Other funds holding BRKR
OAG
PCA
SC
SHCM
Marshall Wace's BRKR Position: Q2 2026 in Review
Marshall Wace increased its Bruker (BRKR) stake by 16% in Q2 2026, buying an estimated $634K and bringing the position to 99,032 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1282.
Marshall Wace first reported a position in BRKR in Q2 2015 and has held it in 34 quarters since. The position peaked at $88.7M in Q2 2024. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.
- Marshall Wace held 99,032 shares of Bruker worth $5.96M as of Q2 2026.
- Marshall Wace bought 13,592 Bruker shares in Q2 2026, an estimated $634K.
- Bruker made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1282 holding.
- Marshall Wace first reported a position in Bruker in Q2 2015 and has held it in 34 quarters since.
- Marshall Wace's Bruker position peaked at $88.7M in Q2 2024.
- 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.